You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY21 is not expected to be complete until September, 2022.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. Image-Guided System for Cancer Intervention

    SBC: ASCENSION TECHNOLOGY CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): This program will demonstrate the potential for commercial success of a novel approach for tracking and displaying the position and orientation of instruments in image-guided cancer interventions. Prototype systems will be demonstrated in selected pancreatic procedures in human subjects. New clinical applications will be examined and commercialization will beg ...

    STTR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  2. Whole Mouse Cryo-Imaging

    SBC: BIOINVISION INC.            Topic: N/A

    DESCRIPTION (provided by applicant): BioInVision, Inc. and Case Western Reserve University researchers will develop a cryo-imaging system for 3D imaging of mice. It will serve very many applications in biological research and the biotechnology industry, in cluding mouse anatomical phenotyping, drug delivery, imaging agents, metastastic cancer, pathogen/immune system response, and stem cells/regene ...

    STTR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  3. Durable Muscle-Prosthetic Bond for Artificial Tendons

    SBC: CARDIOENERGETICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): A coupling mechanism with the strength to fix a forcefully contracting muscle to a totally inert prosthesis, or to bone, would meet a serious and common need in clinical orthopaedics. We have explored a new approach t o such a coupling. The hypothesis was that a coupling prosthesis with a low-mass, high-surface configuration designed to transfer force by shea ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  4. Wireless Movement Disorder Monitor

    SBC: CLEVELAND MEDICAL DEVICES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The objective is to design, build, and clinically assess a Wireless Movement Disorder Monitor (WMDM) specifically tailored to Parkinson's disease (PD). Major PD symptoms that affect quality of life include tremor, bra

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  5. Ph.II: Innovative Methods for Function and Disability Assessment

    SBC: CRECare LLC            Topic: N/A

    DESCRIPTION (provided by applicant): We propose applying innovative measurement technology to develop and disseminate a comprehensive function and disability assessment instrument for use in gerontological research and practice. This technology offers an e ffective method to resolve the classic conflict between practicality and psychometric adequacy faced by traditional standardized outcome measur ...

    STTR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  6. Phase II: COMPUTER ADAPTIVE TESTING OF PEDIATRIC SELF CARE AND SOCIAL FUNCTION

    SBC: CRECare LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Our objective is to achieve a major advance in the technology used to assess disability in children and youth. Measurement and practical requirements for identifying disability and evaluating individual progress across pediatric age groups and care settings present a serious dilemma to current fixed-item survey instruments. In Phase I proposals, we have develo ...

    STTR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  7. Sensor Fusion Software to aid in response and evacuation of subterranean incidents

    SBC: DAX TECHNOLOGIES INTERNATIONAL            Topic: HSB071002

    The speed at which an attack is detected is a critical trigger for all responses to follow. The accurate determination of the type of attack will determine the type of emergency personnel and response needed. The location will determine the target response area as well as determine by proximity which of the responders that are available can be first on the scene. Therefore, a system that can do th ...

    SBIR Phase II 2008 Department of Homeland Security
  8. Transmucosal Intra-Oral Drug Delivery System for THC

    SBC: ElSohly Laboratories, Incorporated            Topic: N/A

    DESCRIPTION (provided by applicant): Delta-9-Tetrahydrocannabinol (THC), the active ingredient in the cannabis plant, has a wide range of pharmacological properties of therapeutic value. The drug has been approved by the Food and Drug Administration (FDA) (Marinol(r) soft gelatin capsules) for the treatment of nausea and vomiting associated with chemotherapy and for appetite stimulation in AIDS p ...

    STTR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  9. Novel Transgenic Rabbit Model for Cardiovascular Disease

    SBC: EVERGEN BIOTECHNOLOGIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Cardiovascular disease (CVD) is the single most common cause of death in the United States. Although the study of the CVD has greatly benefited from the use of gene-targeted transgenic mouse models, these small rodents do not accurately reflect human cardiovascular physiology. The Rabbit would be an excellent animal model for CVD research, considering its many ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  10. DNA Diagnostic System for Statin Safety and Efficacy

    SBC: GENOMAS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Statins are the most prescribed drugs in the world. Their efficacy in primary and secondary prevention of cardiovascular disease as well as beneficial pleiotrophic and anti-inflammatory effects have fostered increasingl y aggressive usage and dosage. Their main clinically relevant safety risk is statin-induced myopathy (SIM) evidenced clinically as a constellat ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government